S 02625 – New YorkStatus: Inactive / Dead
Year Introduced: 2015
Link: http://assembly.state.ny.us/leg/?default_fld=&bn=S02625&term=2015&Summary=Y&Actions=Y&Text=Y&Votes=Y - jump_to_Actions
PHARMACEUTICAL MANUFACTURER AND LABELER MARKETING EXPENSES: would require all manufacturers and labelers of prescription drugs dispensed in New York, that engage in marketing activities within the state, to annually report its marketing expenses to the New York Department of Health.
The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.